跳至主要内容
临床试验/NCT04140175
NCT04140175终止不适用

A Multicenter, Observational Cohort Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Attributable to Suspected or Confirmed Endometriosis

AbbVie117 个研究点 分布在 1 个国家目标入组 291 人开始时间: 2020年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
291
试验地点
117
主要终点
Percentage of participants who underwent surgical interventions for the treatment of CPP and/or DYS

研究概览

简要总结

This study will describe historic, current, and evolving treatment pathways, treatments, and interventions in women with a suspected or confirmed diagnosis of endometriosis in order to better understand the impact of early intervention on the disease or its symptoms. Length of treatment is dependent on standard of care treatment provided and all study information will be collected during routine standard of care visits.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women of reproductive age (between their first menstrual cycle and before onset of menopause).
  • Women who have experienced chronic pelvic pain (CPP) and/or dysmenorrhea (DYS) for at least 6 months prior to enrollment without symptom improvement with non-steroidal anti-inflammatory drugs (NSAIDs) or hormone/medical treatment.
  • Women with suspected or confirmed endometriosis (EM) at time of enrollment.
  • Women with CPP and/or DYS impacting daily activities as determined by their treating physician.
  • Able to read, understand and respond to patient questionnaires.
  • Willing to sign a patient authorization and/or informed consent form (ICF) and agree to disclose personal health information.
  • NOTE: For pediatric patients, parental/guardian assent/ICF is also required.

排除标准

  • Women with chronic pelvic pain (CPP) and/or dysmenorrhea(DYS) for reasons other than endometriosis (EM).
  • Women who have had a hysterectomy and/or bilateral ovary removal (oophorectomy).
  • Women who are pregnant or planning to become pregnant.
  • Women currently using assisted reproductive technologies such as in vitro fertilization (IVF).
  • Women with a history of, or current malignancy (with or without systemic chemotherapy) with the exception of basal cell carcinoma of the skin.
  • Women who are currently participating in an interventional clinical trial.

结局指标

主要结局

Percentage of participants who underwent surgical interventions for the treatment of CPP and/or DYS

时间窗: From onset of CPP and/or DYS to up to 4 years following study enrollment.

Percentage of participants who underwent surgical interventions for the treatment of CPP and/or DYS at any point from onset of CPP and/or DYS and study completion.

Percentage of participants undergoing hysterectomy

时间窗: From study enrollment (Week 0) to up to 4 years.

Percentage of participants undergoing hysterectomy during study enrollment.

Percentage of participants undergoing infertility treatment

时间窗: From study enrollment (Week 0) to up to 4 years.

Percentage of participants undergoing infertility treatments during study enrollment.

Percentage of participants undergoing surgery

时间窗: From study enrollment (Week 0) to up to 4 years.

Percentage of participants undergoing surgery as treatment for CPP and/or DYS.

Percentage of participants receiving specific treatment sequences for the treatment of CPP and/or DYS

时间窗: From onset of CPP and/or DYS to up to 4 years following study enrollment.

Treatment sequences will be identified from the data. Treatment switching, add-on treatment, and discontinuations (including reasons) will be collected wherever possible.

Percentage of participants using specific medications for the treatment of chronic pelvic pain (CPP) and/or dysmenorrhea (DYS)

时间窗: From onset of CPP and/or DYS to up to 4 years following study enrollment.

Data regarding medication use for CPP and/or DYS will be collected from participant medical records, health care provider questionnaires, and participant completed questionnaires.

Number of surgical interventions for the treatment of CPP and/or DYS

时间窗: From onset of CPP and/or DYS to up to 4 years following study enrollment.

Number of surgical interventions for the treatment of CPP and/or DYS.

Percentage of participants with complications associated with surgery

时间窗: From study enrollment (Week 0) to up to 4 years.

Percentage of participants with complications associated with surgery.

次要结局

未报告次要终点

研究者

发起方
AbbVie
申办方类型
Industry
责任方
Sponsor

研究点 (117)

Loading locations...

相似试验